# Velocity Financial, Inc.: financial statements, quarterly

VEL · NYSE · CIK 1692376 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/vel.md) · [Financials](/companies/vel/financials.md) · [Filings](/companies/vel/filings.md) · [Insiders](/companies/vel/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/vel/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Income tax | $m | [5.1](/filings/0000950170-25-037433.md) | [5.1](/filings/0000950170-25-037433.md) | [5.9](/filings/0001193125-26-102677.md) | [5.2](/filings/0001193125-26-102677.md) | [5.6](/filings/0001193125-26-102677.md) | [11.2](/filings/0001193125-26-102677.md) | [8.2](/filings/0001193125-26-209674.md) | [7.8](/filings/0001193125-26-335807.md) | [10.0](/filings/0001193125-26-102677.md) | [15.3](/filings/0001193125-26-102677.md) | [8.6](/filings/0001193125-26-209674.md) | [9.5](/filings/0001193125-26-335807.md) |
| Net income | $m | [12.1](/filings/0000950170-25-037433.md) | [17.4](/filings/0000950170-25-037433.md) | [17.3](/filings/0001193125-26-102677.md) | [14.8](/filings/0001193125-26-102677.md) | [15.8](/filings/0001193125-26-102677.md) | [20.6](/filings/0001193125-26-102677.md) | [18.9](/filings/0001193125-26-209674.md) | [26.0](/filings/0001193125-26-335807.md) | [25.4](/filings/0001193125-26-102677.md) | [34.8](/filings/0001193125-26-102677.md) | [22.4](/filings/0001193125-26-209674.md) | [25.2](/filings/0001193125-26-335807.md) |
| Diluted EPS | $ per share | [0.35](/filings/0000950170-24-123616.md) | not reported | [0.49](/filings/0000950170-25-062027.md) | [0.42](/filings/0000950170-25-105342.md) | [0.44](/filings/0001193125-25-270220.md) | not reported | [0.51](/filings/0001193125-26-209674.md) | [0.69](/filings/0001193125-26-335807.md) | [0.65](/filings/0001193125-25-270220.md) | not reported | [0.57](/filings/0001193125-26-209674.md) | [0.64](/filings/0001193125-26-335807.md) |
| Basic EPS | $ per share | [0.37](/filings/0000950170-24-123616.md) | not reported | [0.52](/filings/0000950170-25-062027.md) | [0.45](/filings/0000950170-25-105342.md) | [0.48](/filings/0001193125-25-270220.md) | not reported | [0.55](/filings/0001193125-26-209674.md) | [0.69](/filings/0001193125-26-335807.md) | [0.66](/filings/0001193125-25-270220.md) | not reported | [0.57](/filings/0001193125-26-209674.md) | [0.64](/filings/0001193125-26-335807.md) |

- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [29.4](/filings/0000950170-24-123616.md) | [40.6](/filings/0001193125-26-102677.md) | [34.8](/filings/0000950170-25-062027.md) | [47.4](/filings/0000950170-25-105342.md) | [44.1](/filings/0001193125-25-270220.md) | [49.9](/filings/0001193125-26-102677.md) | [51.7](/filings/0001193125-26-209674.md) | [79.6](/filings/0001193125-26-335807.md) | [99.0](/filings/0001193125-25-270220.md) | [92.1](/filings/0001193125-26-335807.md) | [87.1](/filings/0001193125-26-209674.md) | [76.1](/filings/0001193125-26-335807.md) |
| Total assets | $m | [4,117](/filings/0000950170-23-058461.md) | [4,405](/filings/0000950170-25-037433.md) | [4,628](/filings/0000950170-24-052429.md) | [4,873](/filings/0000950170-24-089502.md) | [5,202](/filings/0000950170-24-123616.md) | [5,527](/filings/0001193125-26-102677.md) | [5,972](/filings/0000950170-25-062027.md) | [6,476](/filings/0000950170-25-105342.md) | [6,959](/filings/0001193125-25-270220.md) | [7,382](/filings/0001193125-26-335807.md) | [7,591](/filings/0001193125-26-209674.md) | [7,963](/filings/0001193125-26-335807.md) |
| Total liabilities | $m | [3,697](/filings/0000950170-23-058461.md) | [3,968](/filings/0000950170-25-037433.md) | [4,172](/filings/0000950170-24-052429.md) | [4,399](/filings/0000950170-24-089502.md) | [4,715](/filings/0000950170-24-123616.md) | [5,007](/filings/0001193125-26-102677.md) | [5,405](/filings/0000950170-25-062027.md) | [5,875](/filings/0000950170-25-105342.md) | [6,321](/filings/0001193125-25-270220.md) | [6,706](/filings/0001193125-26-335807.md) | [6,895](/filings/0001193125-26-209674.md) | [7,238](/filings/0001193125-26-335807.md) |
| Shareholders' equity | $m | [416](/filings/0000950170-23-058461.md) | [433](/filings/0000950170-25-037433.md) | [453](/filings/0000950170-24-052429.md) | [471](/filings/0000950170-24-089502.md) | [485](/filings/0000950170-24-123616.md) | [517](/filings/0001193125-26-102677.md) | [563](/filings/0000950170-25-062027.md) | [598](/filings/0000950170-25-105342.md) | [634](/filings/0001193125-25-270220.md) | [673](/filings/0001193125-26-335807.md) | [693](/filings/0001193125-26-209674.md) | [722](/filings/0001193125-26-335807.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(9.8) d](/filings/0000950170-24-123616.md) | [26.2 d](/filings/0001193125-26-102677.md) | [10.6](/filings/0000950170-25-062027.md) | [11.5 d](/filings/0000950170-25-105342.md) | [(17.6) d](/filings/0001193125-25-270220.md) | [33.3 d](/filings/0001193125-26-102677.md) | [3.5](/filings/0001193125-26-209674.md) | [7.7 d](/filings/0001193125-26-335807.md) | [11.5 d](/filings/0001193125-25-270220.md) | [(4.5) d](/filings/0001193125-26-102677.md) | [12.1](/filings/0001193125-26-209674.md) | [3.7 d](/filings/0001193125-26-335807.md) |
| Capital expenditure | $m | [0.0 d](/filings/0000950170-24-123616.md) | [0.1 d](/filings/0001193125-26-102677.md) | [0.0](/filings/0000950170-25-062027.md) | [0.1 d](/filings/0000950170-25-105342.md) | [0.1 d](/filings/0001193125-25-270220.md) | [0.1 d](/filings/0001193125-26-102677.md) | [0.1](/filings/0001193125-26-209674.md) | [0.1 d](/filings/0001193125-26-335807.md) | [0.1 d](/filings/0001193125-25-270220.md) | [0.1 d](/filings/0001193125-26-102677.md) | [0.0](/filings/0001193125-26-209674.md) | [0.1 d](/filings/0001193125-26-335807.md) |
| Share repurchases | $m | [0.0 d](/filings/0000950170-24-123616.md) | [0.0 d](/filings/0001193125-26-102677.md) | [1.3](/filings/0000950170-24-052429.md) | [0.3 d](/filings/0000950170-25-105342.md) | [0.0 d](/filings/0001193125-25-270220.md) | [0.0 d](/filings/0001193125-26-102677.md) | [2.2](/filings/0001193125-26-209674.md) | [5.0 d](/filings/0001193125-26-335807.md) | [0.2 d](/filings/0001193125-25-270220.md) | [0.0 d](/filings/0001193125-26-102677.md) | [4.5](/filings/0001193125-26-209674.md) | [2.7 d](/filings/0001193125-26-335807.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [34.2](/filings/0000950170-23-058461.md) | [34.1](/filings/0000950170-24-052429.md) | [34.1](/filings/0000950170-24-089502.md) | [34.7](/filings/0000950170-24-123616.md) | [35.4](/filings/0000950170-25-062027.md) | [35.6](/filings/0000950170-25-105342.md) | [35.9](/filings/0001193125-25-270220.md) | [36.8](/filings/0001193125-26-209674.md) | [37.8](/filings/0001193125-26-335807.md) | [38.8](/filings/0001193125-25-270220.md) | [39.2](/filings/0001193125-26-209674.md) | [39.3](/filings/0001193125-26-335807.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 39,481,457 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0001193125-26-335807.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.